Inflammatory markers in cardiovascular disease; lessons learned and future perspectives.

CONCLUSION: There is significant evidence regarding the role of consolidated and novel inflammatory markers in the field of diagnosis and prognosis of CVD. However, multimarker model assessment, validation of cut-off values and cost-effectiveness analyses are required, in order for those markers to be integrated into daily clinical practice. PMID: 32188386 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32188386?dopt=Abstract

Source: Current Vascular Pharmacology - March 16, 2020 Category: Drugs & Pharmacology Authors: Patoulias D, Stavropoulos K, Imprialos K, Athyros V, Grassos H, Doumas M, Faselis C Tags: Curr Vasc Pharmacol Source Type: research